Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review - Wikidata - awgldk - TriplyDB

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

http://www.wikidata.org/entity/Q26746192

about

The cannabis withdrawal syndrome: current insights A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial.Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013.Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences.Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability.Predictors of Topiramate Tolerability in Heavy Cannabis-Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal.Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.

P2860

Q30313180-3A938077-67DC-4FCD-ADBD-C82FC30FB906 Q46333726-016B3F5B-2DED-45C6-A492-A8D0C916EF93 Q47550362-8D55321E-7B08-45D3-BC26-A5819B7676DC Q47669922-A4E53626-0E57-47B0-852D-90FD363E9F2F Q50066240-24D0EE24-EF57-47FF-87B5-BCB965FF56B1 Q50082799-58724DA1-2FF1-4B6C-87FC-C5C3A4A082D8 Q50101197-5D2AFF55-1689-4EF0-A290-3D0798582FD1 Q53416709-671EACBD-341C-4A73-B36A-EB49D6159254 Q53593654-8E74EB80-ED8F-4838-9976-F86DAE3AF682

P2860

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

http://www.wikidata.org/entity/Q26746192

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

@ast

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

@en

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

@nl

type

label

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

@ast

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

@en

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

@nl

prefLabel

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

@ast

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

@en

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

@nl

P1433

Q26746192-01287372-5C92-4D09-8BD8-5B1A5CA262EC

P1476

Q26746192-0171FE66-4ED6-4BE4-97B0-B023B4D3EE9D

P2093

Q26746192-65C56386-544B-47C1-A9F8-492A315E7806

Q26746192-E5EF3954-1D55-46C2-91B2-A79D4FD69E7F

P2860

Q26746192-00AB66F7-2867-414C-A7BD-6868AD3A4838

Q26746192-08E26973-9B7A-4EED-A390-9B858DAFD242

Q26746192-12024176-5006-4539-89D4-D7262F248DCB

Q26746192-128682D8-0A72-4E77-9A45-D64DA8666B33

Q26746192-15BEF0B2-38D5-4275-9F2F-3B20497094ED

Q26746192-15CEEAE9-AEEE-491F-B1D7-9995148E6978

Q26746192-166B2509-DED3-4753-8E93-013FDE7432DB

Q26746192-1FF3CBCE-EADF-46D5-B229-352198C19721

Q26746192-290C9FCB-3986-431F-8D6E-77A65EA1E3A1

Q26746192-2B52E341-CF5B-42A9-AF19-31F26A3E6F9A

P304

Q26746192-AA933B4E-EF27-4266-B525-E13D020F754B

P31

Q26746192-AE71AD73-CBD6-4A6E-A36C-EFDDAF99423D

P3181

Q26746192-10DEA16F-5611-4A91-A55D-176D52B3D8AE

P356

Q26746192-6DF1B0FF-9A0A-4D09-B89F-18BB7295B42D

P407

Q26746192-A9BCD8B5-C943-4B1F-BE46-EF19AA64B95F

P478

Q26746192-4B499FBF-7FD8-448C-A9A5-803B6DCC21A8

P577

Q26746192-FEFA09BB-26E7-4136-89DE-EA3C9C13B041

P698

Q26746192-E635D509-EF39-4B80-95BB-539722E6C9EF

P921

Q26746192-193C7BD6-1DE6-48B3-9688-83A2CA5B3FBF

P932

Q26746192-A0013013-E5E4-46B3-AA3B-C33B8BEA1A77

P3181

P356

P1433

Substance Abuse and Rehabilitation

P1476

Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review

@en

P2093

Izabella Pokorski

http://www.w3.org/2001/XMLSchema#string

Jan Copeland

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabis Use and Earlier Onset of Psychosis

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

The endocannabinoid system as a target for the treatment of cannabis dependence

The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration

Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction

DSM-5 criteria for substance use disorders: recommendations and rationale

Should burden of disease estimates include cannabis use as a risk factor for psychosis?

N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study

The time course and significance of cannabis withdrawal.

Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis

P304

41-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1886339

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/SAR.S89857

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27217809

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

4862355

http://www.w3.org/2001/XMLSchema#string